Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

Aesica and CMIC Sign Collaborative Agreement

Published: Thursday, October 17, 2013
Last Updated: Thursday, October 17, 2013
Bookmark and Share
Memorandum of Understanding between the two companies will identify reciprocal consultation and manufacturing opportunities for clients in Japan and Europe whilst enabling joint collaborative development in the US.

Aesica Pharmaceuticals Limited and CMIC HOLDINGS Co., Ltd. have announced the signing of a Memorandum of Understanding for the reciprocal development of sales and marketing opportunities for respective clients in Europe and Japan.

Furthermore, both companies will work closely together to develop commercial opportunities across the US market.

Under the terms of the Memorandum of Understanding on collaborative agreement, Aesica and CMIC will exploit corporate synergies between the two companies and form a very close working relationship through which a collaborative approach to sales and marketing and customer liaison is set to be developed for the benefit of their customers. This initiative will form the initial basis of a supply and quality agreement.

Specifically, the reciprocal marketing of capabilities will be used by Aesica to proactively seek expansion of business opportunities in Japan and the US, collaborating with CMIC customers who may require consultation and manufacturing in Europe.

Equally, CMIC is looking to expand global commercial business opportunities outside of the Japanese market, collaborating with Aesica customers who may require consultation or manufacturing in Japan. Additionally, both parties will pursue joint collaborative development of the US market.

Dr Robert Hardy, CEO of Aesica commented: “This agreement will provide a tremendous opportunity to develop business and commercial opportunities for our customers in the Japanese market and in the US, whilst providing solid scope for us to expand our market share in these regions. We look forward to forging an extremely close working relationship and partnership between our two companies”.

Kazuo Nakamura, Chairman and CEO of CMIC added: “There are tremendous synergies between CMIC and Aesica which will be exploited to the full commercial benefit of customers of each company. Whilst CMIC is a leading Japanese, full service contract development and manufacturer of formulated products for the pharmaceutical industry, with established manufacturing sites in Japan, Korea and the USA, Aesica is an international CDMO operating in the UK, Germany and Italy across both API and formulated products. The combined, European, Japanese and US commercial expertise and presence is enormous.”

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More Than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Aesica Concentrates Investment in Lucrative German Formulations Business
Zwickau site introduces roller compaction unit for dry granulation production.
Saturday, July 12, 2014
Aesica Announces Collaboration with QRxPharma
Agreement for the worldwide promotion of Stealth Beadlets® abuse deterrence technology.
Tuesday, July 23, 2013
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
How a Genetic Locus Protects Adult Blood-Forming Stem Cells
Mammalian imprinted Gtl2 protects adult hematopoietic stem cells by restricting metabolic activity in the cells' mitochondria.
Genetic Basis of Fatal Flu Side Effect Discovered
A group of people with fatal H1N1 flu died after their viral infections triggered a deadly hyperinflammatory disorder in susceptible individuals with gene mutations linked to the overactive immune response, according to a recent study.
New Tech Vastly Improves CRISPR/Cas9 Accuracy
A new CRISPR/Cas9 technology developed by scientists at UMass Medical School is precise enough to surgically edit DNA at nearly any genomic location, while avoiding potentially harmful off-target changes typically seen in standard CRISPR gene editing techniques.
The MaxSignal Colistin ELISA Test Kit from Bioo Scientific
Kit can help prevent the antibiotic apocalypse by keeping last resort drugs out of the food supply.
"Good" Mozzie Virus Might Hold Key to Fighting Human Disease
Australian scientists have discovered a new virus carried by one of the country’s most common pest mosquitoes.
Non-Disease Proteins Kill Brain Cells
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer’s and Parkinson’s have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
Closing the Loop on an HIV Escape Mechanism
Research team finds that protein motions regulate virus infectivity.
New Class of RNA Tumor Suppressors Identified
Two short, “housekeeping” RNA molecules block cancer growth by binding to an important cancer-associated protein called KRAS. More than a quarter of all human cancers are missing these RNAs.
Potential Treatment for Life-Threatening Viral Infections Revealed
The findings point to new therapies for Dengue, West Nile and Ebola.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos